0001638833-21-000028.txt : 20210302 0001638833-21-000028.hdr.sgml : 20210302 20210301173851 ACCESSION NUMBER: 0001638833-21-000028 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20210224 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20210302 DATE AS OF CHANGE: 20210301 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Surgery Partners, Inc. CENTRAL INDEX KEY: 0001638833 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062] IRS NUMBER: 473620923 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37576 FILM NUMBER: 21699884 BUSINESS ADDRESS: STREET 1: 310 SEVEN SPRINGS WAY STREET 2: SUITE 500 CITY: BRENTWOOD STATE: TN ZIP: 37027 BUSINESS PHONE: 615-234-5900 MAIL ADDRESS: STREET 1: 310 SEVEN SPRINGS WAY STREET 2: SUITE 500 CITY: BRENTWOOD STATE: TN ZIP: 37027 8-K 1 sgry-20210224.htm 8-K sgry-20210224
0001638833FALSEFebruary 24, 202100016388332021-02-242021-02-24

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 24, 2021
Surgery Partners, Inc.
(Exact Name of Registrant as Specified in Charter)
Delaware001-3757647-3620923
(State or Other Jurisdiction
of Incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
310 Seven Springs Way, Suite 500
Brentwood, Tennessee 37027
(Address of Principal Executive Offices) (Zip Code)
(615) 234-5900
(Registrant’s Telephone Number, Including Area Code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, par value $0.01 per shareSGRYThe Nasdaq Global Select Market
Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o



Item 5.02 Departure of Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On February 24, 2021, the Board of Directors (the “Board”) of Surgery Partners, Inc. (the “Company”) increased the number of Class II directors serving on the Board from two to three and elected Dr. Patricia A. Maryland to fill the vacancy created by the increase in the number of Class II directors. As a Class II director, Dr. Maryland’s term expires at the 2023 annual meeting of stockholders. The Board has determined that Dr. Maryland is independent in accordance with Nasdaq listing standards.
The Board has not appointed Dr. Maryland to any committees of the Board, and it is unknown which committees of the Board Dr. Maryland will serve on at this time.
Dr. Maryland’s compensation will be materially consistent with other non-employee directors of the Company, as described in the definitive proxy statement for the Company’s 2020 annual meeting of stockholders, filed with the Securities and Exchange Commission on April 17, 2020. Additionally, Dr. Maryland entered into the Company’s standard form of indemnification agreement.
A copy of the press release announcing Dr. Maryland’s election to the Board is filed as Exhibit 99 to this report.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No.
Description
99
104
Cover Page Interactive Data File (embedded within the Inline XBRL document)



SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
SURGERY PARTNERS, INC.
By:
/s/ Jennifer B. Baldock
Jennifer B. Baldock
Executive Vice President, Chief Administrative and Development Officer
Date: March 1, 2021

EX-99 2 a20210224-drmarylandappoin.htm EX-99 Document

image_01a.jpg

SURGERY PARTNERS, INC.
NAMES PATRICIA A. MARYLAND, DR TO BOARD OF DIRECTORS

BRENTWOOD, Tenn., March 1, 2021 (GLOBE NEWSWIRE) - Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading provider of surgical services, today announced that Dr. Patricia A. Maryland has been appointed to serve as an independent director on its Board of Directors. Dr. Maryland’s appointment, which is effective immediately, will increase the size of Surgery Partners’ Board to nine members.
Dr. Maryland joins the Surgery Partners Board with extensive healthcare experience. Her career in healthcare administration spans 40 years, most recently serving as an executive vice president for Ascension and the president and chief executive officer at Ascension Healthcare, a leading non-profit health system operating more than 2,600 sites of care including 150 hospitals and more than 50 senior living facilities in 20 states and the District of Columbia. Prior to that, Dr. Maryland held other executive and management positions in the Ascension organization. Dr. Maryland has been a member of over 25 boards in the nonprofit, private, joint venture, and public sectors and has been the recipient of multiple awards, including being named one of the Top 25 COOs in Healthcare in 2017, one of the Top 25 Women in Healthcare in 2017 and 2015 by Modern Healthcare, Woman of the Year in 2014 by the Healthcare Businesswomen’s Association, and one of Modern Healthcare’s Top 25 Minority Executives in Healthcare also in 2014.
Dr. Maryland received a bachelor’s degree in applied mathematics from Alabama State University, Montgomery, and a master’s degree in biostatistics from the University of California, Berkeley. She holds a Doctorate of Public Health from the University of Pittsburgh, concentrating in health services administration and planning.
“We are pleased to welcome Patricia Maryland to our Board of Directors,” said Wayne DeVeydt, Chairman of Surgery Partners’ Board of Directors. “Her impressive leadership experience and expertise in healthcare delivery as well as her patient-centric approach makes her an ideal Board member for Surgery Partners. We look forward to her valuable contributions as we continue to execute our growth strategy and pursue our mission of enhancing patient quality of life through partnership.”
“I am honored to be joining the Surgery Partners Board,” added Dr. Maryland. “I look forward to supporting the important role Surgery Partners plays in improving the affordability and accessibility of high-quality surgical care and as the only independent surgical facility operator of national size.”
About Surgery Partners
Headquartered in Brentwood, Tennessee, Surgery Partners is a leading healthcare services company with a differentiated outpatient delivery model focused on providing high quality, cost effective solutions for surgical and related ancillary care in support of both patients and physicians. Founded in 2004, Surgery Partners is one of the largest and fastest growing surgical services businesses in the country, with more than 180 locations in 30 states, including ambulatory surgery centers, surgical hospitals, multi-specialty physician practices and urgent care facilities. For additional information, visit www.surgerypartners.com.
Contact:
Surgery Partners Investor Relations
(615) 234-8940
IR@surgerypartners.com
1
EX-101.SCH 3 sgry-20210224.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 4 sgry-20210224_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 5 sgry-20210224_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 6 sgry-20210224_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Written Communications Written Communications Pre-commencement Tender Offer Pre-commencement Tender Offer Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, City or Town Entity Address, City or Town Soliciting Material Soliciting Material Entity Address, Address Line One Entity Address, Address Line One Security Exchange Name Security Exchange Name Document Information [Line Items] Document Information [Line Items] City Area Code City Area Code Cover [Abstract] Entity Central Index Key Entity Central Index Key Entity Tax Identification Number Entity Tax Identification Number Entity File Number Entity File Number Document Type Document Type Document Information [Table] Document Information [Table] Entity Emerging Growth Company Entity Emerging Growth Company Title of 12(b) Security Title of 12(b) Security Amendment Flag Amendment Flag Local Phone Number Local Phone Number Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Trading Symbol Trading Symbol Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name EX-101.PRE 7 sgry-20210224_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 8 image_01a.jpg begin 644 image_01a.jpg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end XML 9 sgry-20210224_htm.xml IDEA: XBRL DOCUMENT 0001638833 2021-02-24 2021-02-24 0001638833 false 2021-02-24 8-K 2021-02-24 Surgery Partners, Inc. DE 001-37576 47-3620923 310 Seven Springs Way, Suite 500 310 Seven Springs Way, Suite 500 Brentwood Brentwood TN 37027 615 234-5900 false false false false Common Stock, par value $0.01 per share SGRY NASDAQ false XML 10 R1.htm IDEA: XBRL DOCUMENT v3.20.4
Cover
Feb. 24, 2021
Document Information [Line Items]  
Document Type 8-K
Document Period End Date Feb. 24, 2021
Entity File Number 001-37576
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 47-3620923
Entity Registrant Name Surgery Partners, Inc.
Entity Address, Address Line One 310 Seven Springs Way, Suite 500
Entity Address, City or Town Brentwood
Entity Address, State or Province TN
Entity Address, Postal Zip Code 37027
City Area Code 615
Local Phone Number 234-5900
Title of 12(b) Security Common Stock, par value $0.01 per share
Trading Symbol SGRY
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Central Index Key 0001638833
Amendment Flag false
EXCEL 11 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 12 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 13 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 14 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.4 html 1 95 1 false 0 0 false 0 false false R1.htm 0001001 - Document - Cover Sheet http://surgerypartners.com/role/Cover Cover Cover 1 false false All Reports Book All Reports sgry-20210224.htm a20210224-drmarylandappoin.htm sgry-20210224.xsd sgry-20210224_cal.xml sgry-20210224_def.xml sgry-20210224_lab.xml sgry-20210224_pre.xml http://xbrl.sec.gov/dei/2019-01-31 true true JSON 17 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "sgry-20210224.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "calculationLink": { "local": [ "sgry-20210224_cal.xml" ] }, "definitionLink": { "local": [ "sgry-20210224_def.xml" ] }, "inline": { "local": [ "sgry-20210224.htm" ] }, "labelLink": { "local": [ "sgry-20210224_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "sgry-20210224_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "sgry-20210224.xsd" ], "remote": [ "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd" ] } }, "elementCount": 25, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2019-01-31": 3, "total": 3 }, "keyCustom": 0, "keyStandard": 95, "memberCustom": 0, "memberStandard": 0, "nsprefix": "sgry", "nsuri": "http://surgerypartners.com/20210224", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "sgry-20210224.htm", "contextRef": "ib40bc1a7e5b946c79f2d1f6a756aab0e_D20210224-20210224", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Cover", "role": "http://surgerypartners.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "sgry-20210224.htm", "contextRef": "ib40bc1a7e5b946c79f2d1f6a756aab0e_D20210224-20210224", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://surgerypartners.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://surgerypartners.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "xbrltype": "stringItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]", "terseLabel": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://surgerypartners.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]", "terseLabel": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://surgerypartners.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://surgerypartners.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://surgerypartners.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://surgerypartners.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://surgerypartners.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://surgerypartners.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://surgerypartners.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://surgerypartners.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://surgerypartners.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://surgerypartners.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://surgerypartners.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://surgerypartners.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://surgerypartners.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://surgerypartners.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://surgerypartners.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://surgerypartners.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://surgerypartners.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://surgerypartners.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://surgerypartners.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://surgerypartners.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://surgerypartners.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 18 0001638833-21-000028-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001638833-21-000028-xbrl.zip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